This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search

pregnancy rhinitis

FREE subscriptions for doctors and students... click here
You have 3 open access pages.

Nasal congestion is a common companion to pregnancy, with pregnancy rhinitis, i.e., nasal congestion absent an identified cause other than pregnancy, occurring in roughly one in five pregnancies

  • common manifestations of pregnancy rhinitis include nasal congestion and rhinorrhea; both of these symptoms are exacerbated by ongoing use of over-the-counter (OTC) nasal decongestant sprays

  • management options:
    • environmental modification can optimize intranasal functioning
      • simple measures such as elevation of the head of the bed, adequate fluid intake, proper room humidity, and avoidance of cigarette smoke and other environmental irritants are essential
    • intranasal saline instillation is a low risk and often effective intervention, as are OTC nasal strips
    • exercise
    • nasal corticosteroids could be effective, but they have not been shown to be effective in isolated pregnancy rhinitis
      • nasal corticosteroids have not been shown to be effective in a trial of fluticasone (1)
      • however nasal corticosteroids are often used in the management of this condition
      • congenital malformations were studied in 2014 infants whose mothers had used inhaled budesonide for asthma in early pregnancy (2)
        • no increase in rate of congenital malformations was observed compared with the general population rate
    • nasal decongestants provide good temporary relief, women tend to overuse them
      • in the last few decades, the awareness of rhinitis medicamentosa has increased
        • resulting rhinitis medicamentosa can produce complete nasal obstruction and a host of subsequent discomforts, including substantial sleep disturbances
        • women with pregnancy rhinitis tend to use nasal decongestants for prolonged periods of time, and are at risk of developing this additional condition
    • systemic corticosteroids and oral decongestants should not be used
    • invasive methods of turbinate reduction may be effective, but are not recommended


  • rhinitis medicamentosa as a contributing factor
    • rhinitis medicamentosa, a syndrome of rebound nasal congestion following use of intranasal topical decongestants, frequently exacerbates the nasal congestion of pregnancy rhinitis
      • rebound hypercongestion, coupled with the memory of initial relief, thereby initiates a cycle of progressive use and accelerating hypercongestion. Such hypercongestion quickly reaches a level of complete nasal obstruction marked by total unresponsiveness to further applications of topical decongestants
      • any patients using intranasal decongestants for a longer period should be advised to discontinue use immediately.



The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions Ltd®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions Ltd® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.